Cellomatics Quarterly Newsletter (Spring, 2024)

Our guiding principle is Our Expertise, Your Discovery. It’s what drives us here at Cellomatics.

"Welcome to our latest newsletter.??

Cellomatics has had a strong start to 2024 as we have grown our team and welcomed eight new members as well as celebrating four internal promotions.?These appointments and promotions will consolidate our position as a specialist biology CRO by broadening and deepening our service offerings in 2024.?

We continue to update our website, ensuring that our data sets are as current and accurate as possible as we continue to add new assays to our offering at Cellomatics. The latest pages to be updated are our?Immunology?and?Oncology?pages?which now feature interactive illustrations as well as up-to-date data sets on the services we offer at Cellomatics.?

We are proud to support the important work of our clients, so if you think we can help you,?please get in touch.”?

What our clients say

Cellomatics Biosciences is a multi award-winning laboratory-based Contract Research Organisation specialising in?Oncology,?Immuno-oncology,?Immunology,?Inflammation?and?Respiratory?therapeutic areas.

Over the years we have worked with many impactful businesses and have built long-standing relationships with our clients, resulting in some excellent feedback.

Steve Holmes PhD, Former CEO of Capella Bioscience,?said:

“I have worked with Cellomatics on three different therapeutic antibody projects with great success.?One project entailed a novel cellular transport assay which Cellomatics set up from scratch. The other two projects involved primary cell based assays which Cellomatics proved to be exceptionally competent in.?The project management was also very good with regular updates and emails with our team. Time wise the projects with Cellomatics ran smoothly and to plan.?The quality of work and reports met all my expectations and I found the pricing to be very competitive compared to other quotations. Overall I would not hesitate to recommend them.”

Hires and promotions

It’s been a busy year so far at Cellomatics as in January we welcomed eight new starters to the team and celebrated four promotions. These new appointments and internal promotions will ensure Cellomatics' continuous growth.

Read more about our promotions and appointments?here.

We would like to also give a warm welcome to Jyoti Mundra, PhD who has recently joined the Cellomatics team to lead our business development efforts in the United States.?

Jyoti is based in New Jersey, US and will be helping us to continue with our international expansion into the US market.

Recent content

In our latest instalment of our ‘Meet the team’ series we sat down with our Bioassay Study Manager Dr Alex Timmis. Alex has been with Cellomatics since 2021 and was one of our recent promotions.

Take a look at the video?here.?

The team have also been working on writing some scientific articles for the website.?In February we shared a piece on Immune Cell Chemotaxis written by a Senior Bioassay Scientist which?delves into immune cell chemotaxis and the?capabilities we have?for this research?at Cellomatics.

Read the piece?here.?

To mark Parkinson’s Awareness Month?our Senior Bioassay Scientist Dr Gareth Edwards wrote a piece discussing the role of neuroinflammation and its contribution to the?global?increase in dementia and associated neurodegenerative neuropathies.

Read 'Posing (Neuro)inflammatory questions about dementia'?here.?

Achievements

In March Cellomatics attended the first ever?One Nucleus Awards?where we were shortlisted in the R&D Services Provider Category.While we were not crowned winners of the award we had fierce competition in two large CROs and so were thrilled to be able to represent the Midlands region at the ceremony.?

Learn more?here.

On 9th May Cellomatics CEO and Founder Dr Shailendra Singh was joined by team members Dr Lara De Tomasi, Dr Eleni Birli, Dr Katie Hudson and Dr Emma Barker at the?Medilink Midlands Business Awards 2024, where Cellomatics was presented with the Export Achievement Award.

Commenting on the evening, Shailendra said: “I am extremely proud and delighted to accept this award on behalf of the Cellomatics team. This award win is a testament to the hard work and tireless efforts of the Cellomatics staff. We have previously been shortlisted in this category but winning the award showcases our continued expansion and the overseas success we have achieved.

“We are proud to be a life sciences company based in the Midlands and are looking forward to what the future holds at Cellomatics.”

Read our blog to find out more?here.?

A focus on: Immunology

Our team have focused on showcasing our Inflammation expertise with the creation of?an?Immunology Hub?where you can view a selection of downloadable technical notes highlighting our assays, data sets and offering.?

Cellomatics offers well-validated preclinical complex human/animal cell-based models to investigate the role of immune cells in regulating key signalling pathways in inflammatory diseases and cancer.

We have the capabilities and expertise in-house to recruit healthy volunteers, collect and isolate fresh immune cells for downstream functional assays. These models are suitable for low to high throughput immunology studies.

At Cellomatics we offer a range of Immunology assays as shown below.

For our free Immunology?pdf download, click here.

Find out more here.

Keeping in touch

If we can assist you in providing validated clinically relevant?in vitro?disease models or bespoke??in?vitro?models using cell-based approaches to support the progression of your assets to the next stage of drug development, then please?get in touch.??